Dechra Pharmaceuticals PLC — Remuneration Information 2014

Apr 7, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2388E

Dechra Pharmaceuticals PLC

07 April 2014

7 April 2014

Dechra® Pharmaceuticals PLC

(Dechra or the Company)

Director / PDMR shareholding

Grant of SAYE options:

Dechra Pharmaceuticals PLC announces that on 7 April 2014, the following Directors and PDMRs were granted options over ordinary shares of 1p each in the Companypursuant to the Dechra Pharmaceuticals Save As You Earn Scheme (the "Options").

The Options have been granted with an exercise price of £5.52.

Name	Capacity	Options Granted
Ian Page	Director	1,630
Anne-Francoise Nesmes	Director	1,630
Zoe Goulding	PDMR	652

For further information, please contact:

Zoe Goulding, Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQKODBNBKDQQK